4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-008045
Chief Financial Officer acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moretti August J · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-12 | Exercise or conversion : show line 1 in the form | +1,000 | $9.41 | $9,410 | 2,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-12 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −1,000 | 223,060 | D |
Loading xslF345X03/doc1.xml…